AbogenBio News and Activities
Presence
AbogenBio develops biotechnology medicines and vaccines based on RNA technology. Its main products and services include vaccine development, drug discovery, and manufacturing support for healthcare providers, research partners, and pharmaceutical companies.
AbogenBio products and services overview:
- RNA vaccines
- RNA therapeutics
- Drug discovery
- Manufacturing services
- Delivery systems
Revenue: ~$0 million
Employees: 500
Headquarters: Suzhou, China
AbogenBio is one of the...
Executives
View the org chart displaying its 10 main executives
Most searched biographies at AbogenBio
- Ying Bo, Chief Executive Officer
- Yan Zhang, Chief Financial Officer
- Nancy Wang, Senior Director of Human Resources
Create your alert
to follow the executive moves at AbogenBio.
Biotechnology
AbogenBio has 2,422 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- BridgeBio has just announced a $1,000 Million fundraising (posted on July 2 2026).
- Flare Therapeutics has just announced a $85 Million fundraising (posted on July 2 2026).
- Ipsen has announced the acquisition of Memo Therapeutics (posted on July 1 2026).
Popular contacts in Biotechnology
News
Press releases by AbogenBio
Social media about AbogenBio
- AbogenBio on Wikipedia, Google News & Yahoo Finance
- AbogenBio on LinkedIn, X (Twitter) & YouTube
